Regarding your question as to p53 activation testing, it is not under our control when this testing will be done. If it was it would of have been done "yesterday". This is very sophisticated and expensive testing. The hospital and the lab know best when enough samples have been collected and then begin testing. I am as impatient as you.

Regarding the pk data on the first cohort, I will update shareholders when we receive the report. I assume there are no issues seen at the lab as the trial is going full speed ahead. Remember the pk has nothing to with p53. Its very important for understanding possible toxicity issues, therapeutic index, etc.

We will do our best to update shareholders regularly. In certain instances we will need the hospital's permission.

Best

Leo

On Thu, Jan 10, 2013 at 6:54 AM, xxxxxx wrote:

Good Morning Leo,

I have a question that I would appreciate a response to.

It concerns Lab results: in some of CTIX's PRs in the last month it was mentioned that lab results are expected soon and during a similar time frame it was mentioned that some institutions will want to post results via an article via the institution.

To give me and others perspective, will there be initial posting of lab results throughout the trial? Will some be forth coming as previously pr'd? Or is that now seen as something out of the control of CTIX management? Will we be waiting until post phase 1 for results?

Its a pretty hot issue, since so many of us investors want/need to know if Kevetrin is performing as 'hoped' regarding p53 activation etc.

Any guidance on what to expect regarding lab information released via PRs?

Leo, I again want to thank-you for the great job you are doing on behalf of all shareholders. I for one have only bought shares and even though I'm up close to 300% I have not sold any.

sincerely,

xxxxxx